Obesity

SAN DIEGO — Semaglutide, a GLP-1 receptor agonist approved for treatment of obesity and type 2 diabetes, improved kidney metrics for adults with overweight and obesity without diabetes, according study data.

The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed.

BOSTON — Addiction to ultraprocessed food may be diagnosed similarly to other substance use disorders, and reducing stigma and tailored treatment are both important to improving cardiometabolic health, a speaker reported.

SAN DIEGO — Among African American and white adults with obesity who received kidneys from the same deceased donor, graft failure rates were higher — but so were survival rates — for African American recipients, according to study data.

Expanding access to weight loss medications could save tens of thousands of lives annually, according to an analysis published in PNAS.

BOSTON — In this Healio video exclusive, Virend K. Somers, MD, PhD, discusses his presentation at the Cardiometabolic Health Congress, “Sleep Disorders and Cardiometabolic Health.”

Cardiologists preferred to advise diet and exercise for patients with obesity over currently available obesity medications, but with little personalized tailoring for patients, survey results showed.

DENVER — For women with polycystic ovary syndrome and overweight or obesity, neither oral contraceptive pills nor metformin altered the characteristic markers of metabolic syndrome, either alone or in combination, researchers reported.

Sending young children from low-income households to free summer day camps could help reduce gains in BMI during summer break, according to a randomized clinical trial in JAMA Pediatrics.

DENVER — Obesity prevalence is increasing among reproductive-age people and unhealthy weight is associated with infertility in both sexes, yet the impact of weight reduction on fertility outcomes is complex, according to a speaker.